Macrophage inhibitor factor (MIF) in cutaneous lymphoproliferative diseases

Publisher Website
Google Scholar
Abstract
MIF activity in the sera of patients with mycosis fungoides, Sezary syndrome and cutaneous lymphoma was observed in the sera of 8 of the 10 patients with stage II (infiltrative) mycosis fungoides, but in only 1 of the 8 patients with stage I and in neither of the 2 patients with stage III mycosis fungoides. Two of the 3 patients with Sezary syndrome had MIF in the serum. No MIF was observed in cutaneous lymphoma. Thus, Sezary syndrome and mycosis fungoides are probably T[thymus-derived]-cell diseases, and transitional, prelymphomatous diseases.